Patient Trajectories from Electronic Health Records Suggest Specialty Specific Warning Signs for Common Variable Immunodeficiency
Mester, R.; Chin, A. T.; Tozzo, V.; Stephens, A. V.; Hoffman, H. M.; Riedl, M. A.; Dorsey, M. J.; Gupta, S.; Demirdag, Y. Y.; Sankararaman, S.; Bastarache, L.; Pasaniuc, B.; Butte, M. J.
Show abstract
Background: Common variable immunodeficiency is frequently underrecognized due to its heterogeneous clinical presentation, resulting in diagnostic delays that increase disease-related complications, with each year of delay increasing mortality risk by 4% for the most common inborn error of immunity. Objective: In individuals with established common variable immunodeficiency, we sought to recognize patterns in patient diagnostic trajectories to identify opportunities for interventions to reduce time to diagnosis. Methods: We analyzed retrospective electronic health records data from 139 individuals with physician-confirmed common variable immunodeficiency across five academic health systems representing >10million patients. We evaluated diagnosing specialties and international classification of disease code trajectories in the two years prior to and at common variable immunodeficiency confirmation. Additionally, we construct specialty-specific prediction on a 1:50 case: control cohort using a gradient boosting algorithm. Results: The leading diagnoses at common variable immunodeficiency determination were respiratory (35% of individuals), and individuals with respiratory symptoms were more likely to be diagnosed by Allergy / Immunology than by other specialties (odds ratio 2.9, standard error 0.35, p-value 1.9x10-3) and had a higher frequency of visits to pulmonary disease in the two years prior to diagnosis. Individuals with neoplasms were 50% more likely than other patients (OR 2.0, SE 0.29, p-value 0.02) to receive a diagnosis at each visit, reducing their diagnostic delay by up to a year. We find that a larger ratio of number of specialties visited to the total number of visits is significantly correlated with an increased time to diagnosis. A trajectory-informed specialty-specific prediction improved detection with an area under the precision-recall curve of fifty times the value expected under the null. Conclusions: Individuals referred to Allergy / Immunology have shorter time to diagnosis, and a specialty-specific prediction could improve detection of common variable immunodeficiency. Clinical Implications: Overall, we find that phenotype-specialty interactions may inform targeted interventions to improve common variable immunodeficiency recognition across specialties, reducing diagnostic odyssey and disease-related complications.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors 89%
- The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022 88%
- The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia 87%
Similar papers in this journal
- Pediatric antibiotic use associated with respiratory syncytial virus and influenza in the United States, 2008-2018 89%
- Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection 89%
- Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study’s Final Analysis 89%
Similar papers in this journal
- A machine learning-based phenotype for long COVID in children: an EHR-based study from the RECOVER program 90%
- Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia 90%
- Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA 90%
Similar papers in this journal
Similar papers in this journal
- Optimising COVID-19 Episode Identification Using Serology and PCR/Rapid Antigen Testing: Insights from the BRACE Trial 91%
- Diagnostic performance of the combined nasal and throat swab in patients admitted to hospital with suspected COVID-19 90%
- Duration of SARS-CoV-2 Sero-Positivity in a Large Longitudinal Sero-Surveillance Cohort: The COVID-19 Community Research Partnership 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.